FDA accepts Triferic NDA

FDA accepted for review an NDA from Rockwell Medical Inc. (NASDAQ:RMTI) for Triferic soluble ferric pyrophosphate (SFP) to treat iron deficiency in chronic kidney disease (CKD) patients receiving hemo...